User: Guest  Login
More Searchfields
Simple search
Sort by:
and:
More ...

Jacobson, B.F.; Louw, S.; Mer, M.; Haas, S.; Büller, H.R.; Abdul-Carim, A.T.; Adler, D.; Beaton, A.; de Jong, P.R., van der Jagt, D.; Levy, B.; Pearl, J.; Schapkaitz, E.; Wessels, P.
Venous Thromboembolism-prophylactic and therapeutic practice guideline
S Afr Med J
2009
99
6

More ...

Sanchez-Antequera, Y.; Cengizeroglu, A.; Kopera A.;, Mykhaylyk, O.; Johnston, J,.;
A novel non-viral and viral technology for ex-vivo gene therapy: Magselectofection
1411 Or 84
ESGCT, DGGT, GSZ, AND ISCT 2009
2009

More ...

Trueck, C.; Mykhaylyk, O.; Zimmermann, K.; Wenzel, D.; Becher, U.; Hofmann, A.; Gleich, B.; Fleischmann, B.; Plank, C, Pfeifer, A.
Targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles
1386
ESGCT, DGGT, GSZ, AND ISCT 2009
2009

More ...

Schillinger, U.; Rutz, M.; Fischer C.; Jahnke A.; Walsch F.; Ferizi, M.; Benda, V.; Schwarz B.; Kempf T.; Hirschberger J.; Köstlin, R.; Brill T., Gänsbacher B.; Plank, C.
Adjuvant immunostimulatory therapy by magnetofection prolonged relapse-free survival for fibrosarcoma bearing cats
1384
ESGCT, DGGT, GSZ, and ISCT 2009
2009

More ...

Haas, S
New anticoagulants - towards the development of an "ideal" anticoagulant.
Vasa
2009
38
1
13-29

More ...

Plank, C;Rosenecker, J
Magnetofection: the use of magnetic nanoparticles for nucleic acid delivery.
CSH Protoc
2009
2009
6
pdb.prot5230

More ...

Mykhaylyk, O;Steingotter, A;Perea, H;Aigner, J;Botnar, R;Plank, C
Nucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI.
J Biomed Nanotechnol
2009
5
6
692-706

More ...

Obermeier, A;Matl, FD;Friess, W;Stemberger, A
Growth inhibition of Staphylococcus aureus induced by low-frequency electric and electromagnetic fields.
Bioelectromagnetics
2009
30
4
270-9

More ...

Haas, S;Bauersachs, R
[Prevention of deep vein thrombosis in surgical and non-surgical patients]
Hamostaseologie
2009
29
1
91-5

More ...

Haas, S
Rivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme.
Eur J Haematol
2009
82
5
339-49